DOI: 10.1055/s-00000125

Senologie - Zeitschrift für Mammadiagnostik und -therapie

References

Patnaik A, Rosen LS, Tolaney SM et al.
LY2835219, a novel cell cycle inhibitor selective for CDK4/6, in combination with fulvestrant for patients with hormone receptor positive (HR+) metastatic breast cancer.

J Clin Oncol 2014;
32 (Suppl.) Abstract 534

Download Bibliographical Data

Search in: